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Abstract: Bioreactors have proven useful for a vast amount of applications. Besides classical large-scale
bioreactors and fermenters for prokaryotic and eukaryotic organisms, micro-bioreactors, as specialized
bioreactor systems, have become an invaluable tool for mammalian 3D cell cultures. In this systematic
review we analyze the literature in the field of eukaryotic 3D cell culture in micro-bioreactors within
the last 20 years. For this, we define complexity levels with regard to the cellular 3D microenvironment
concerning cell–matrix-contact, cell–cell-contact and the number of different cell types present at the
same time. Moreover, we examine the data with regard to the micro-bioreactor design including mode
of cell stimulation/nutrient supply and materials used for the micro-bioreactors, the corresponding 3D
cell culture techniques and the related cellular microenvironment, the cell types and in vitro models
used. As a data source we used the National Library of Medicine and analyzed the studies published
from 2000 to 2020.
Keywords: micro-bioreactor; 3D cell culture; scaffolds; microfluidics; material; cellular microenvironment;
tissue engineering; HTS; in vitro models
1. Introduction
Micro-bioreactors (MBRs) represent specialized bioreactor systems that were, unlike their big
brothers, namely classical bioreactors for biotechnological applications or industrial production,
developed for growing mammalian cells and/or tissues in vitro on a smaller scale. In fact, MBRs may
be considered as an intermediate stage towards more complex organ-on-a-chip (OoC) systems as
they incorporate design elements of classical bioreactors, e.g., stirred or perfused flasks/chambers
instead of large-scale tanks, and novel technologies including microfluidic components, cell-scaffolds,
and setups enabling microscopic analysis and cell-based assays which are also part of OoC systems.
Despite the technological advances in the field of OoC systems, MBRs are still prevalent in cell-based
biomedical research and have become invaluable tools in eukaryotic 3D cell culture research because
they (i) provide controllable 3D cell culture conditions usually including an active fluid flow supply,
(ii) enable, unlike large-scale bioreactors, the usage of small amounts of chemical entities and low cell
numbers when primary cell and/or tissue availability is limited, and (iii) depending on the design,
are frequently amenable to microscopic imaging, or other, even more sophisticated analysis techniques,
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which facilitates cell culture evaluation during bioreactor operation. This has led to an ever-increasing
amount of applications which provide insights that have not been possible before. In this context,
a multitude of in vitro studies using 3D cell culture techniques individually or in combination with
MBRs identified the following parameters which are relevant for the modulation of cell behavior:
(i) spatial and temporal gradients of signaling molecules (e.g., growth factors, cytokines, and hormones),
(ii) spatial distribution of cell–extracellular matrix (ECM) interactions, which are also inevitably coupled
with the molecular and mechanical ECM properties, (iii) the spatial distribution of homologous and
heterologous cell–cell contacts, and (iv) biomechanical forces emerging from interstitial fluid flow and
tissue deformation.
Against this background and within the scope of this special issue of Processes bearing the same
title, we would like to give an overview of the work published in the last 20 years in the area of 3D cell
culture in micro-bioreactors and to thereby address the following questions:
• What has been done in the last 20 years in the field of micro-bioreactor design and what are the
applications of such systems?
• Which systems have prevailed up till now?
• What are currently the most common techniques of 3D cell culture-based MBRs?
• Where is the journey taking us?
To answer these questions, we reviewed the studies in the field of 3D cell culture in MBRs between
the years 2000 and 2020 (9 July 2020) systematically with respect to MBR design, the corresponding 3D
cell culture techniques and the related cellular microenvironment, the mode of cell stimulation and/or
nutrient supply, the materials used for MBRs and scaffold fabrication, the applications of the systems
and the used cell type or in vitro model.
In this first part of the review, we analyze the published papers in terms of MBR design; this includes
the used 3D cell culture technique, the mode of fluid flow and MBR materials, the applications of such
systems and the origin and type of the cells in the last 20 years. On the basis of the literature research
results we have structured the different approaches for better clarity by means of the complexity of the
corresponding 3D cell culture techniques used in the systems, hereafter referred to as “complexity level”,
defined the main fluid flow mode and classified the micro-bioreactor types according to their principal
design. Furthermore, as organ-on-a-chip (OoC) systems are sometimes very hard to distinguish from
MBRs with incorporated microfluidics we try to elucidate what distinguishes MBRs from OoC systems,
although barriers are fluent.
In review part two, we provide a more detailed description of the results of our literature research
structured according to the aforementioned complexity levels and with focus on the existing MBR
types and their applications, as well as on common cell/tissue types cultured in such systems. We then
disseminate the different types of MBR applications including simulation studies and finally give an
outlook to future developments in the field of 3D cell culture in MBR. With this review, we hope to be
able to adequately introduce the reader into the great contributions of this special issue of Processes on
Advanced 3D-Cell Culture Techniques in Micro-Bioreactors.
2. Methods and Definitions
For the detection and analysis of the relevant literature, the PubMed® database of the National
Library of Medicine of the National Center for Biotechnology Information (NCBI) at the U.S. National
Library of Medicine (https://pubmed.ncbi.nlm.nih.gov/) was used. The following search terms were
defined to include different spellings of the keywords as well as their synonyms:
1. “3D cell culture” AND “microbioreactor”;
2. (bioreactor OR microbioreactor OR micro-bioreactor) AND (“three-dimensional cell culture” OR
“3D cell culture” OR “3-D cell culture”);
3. (microbioreactor OR micro-bioreactor) AND “tissue engineering”.
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Moreover, secondary literature meeting the same search term results were included (Figure 1).
Based on the results of our literature research we could extract the following parameters which are
characteristic for MBRs and were used to define MBRs in the present review:
• culture volumes of less than 500 mL;
• provision of an active fluid flow, being realized by a pump, a stirring mechanism, piston movements
or mechanical movement of the cell-based constructs in culture medium;





















1:  “3D  cell  culture” AND  “microbioreactor”;  Term  2:  (bioreactor OR microbioreactor OR micro‐
bioreactor) AND (“three‐dimensional cell culture” OR “3D cell culture” OR “3‐D cell culture”); Term 
3: (microbioreactor OR micro‐bioreactor) AND “tissue engineering”. 
Since 3D  cell  culture  comprises many different  techniques, we defined as mentioned before, 
complexity  levels with  regard  to  the  culture  configuration  to  structure  the  different  strategies. 
Cellular complexity levels of the 3D cell culture configurations were defined as follows (Figure 2A): 
Figure 1. Number of publications yielded by the search terms in the period from 2000 to 2020.
Term 1: “3D cell culture” AND “microbioreactor”; Term 2: (bioreactor OR microbioreactor OR
micro-bioreactor) AND (“three-dimensional cell culture” OR “3D cell culture” OR “3-D cell culture”);
Term 3: (microbioreactor OR micro-bioreactor) AND “tissue engineering”.
By using this search strategy, 326 papers were retrieved of which 92 were excluded because they
did not fulfil above mentioned MBR-definitions or because information on the used bioreactor type
was insufficient. In addition to 192 relevant publications, we found 26 reviews and 10 publications
which were dedicated to the simulation of flow rates, shear stress, or also oxygen distribution (Figure 1).
These studies are discussed in the second part of the review. A total of 192 publications was the
basis of the analysis with the corresponding figures and all papers were analyzed with regard to the
following parameters: complexity level, bioreactor type, materials used for fabrication, scaffold- or
non-scaffold-based culture technique, species origin of the cells used, type of organ, type of cells,
and application.
Since 3D cell culture comprises many different techniques, we defined as mentioned before,
complexity levels with regard to the culture configuration to structure the different strategies.
Cellular complexity levels of the 3D cell culture configurations were defined as follows (Figure 2A):
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1. Complexity level 1: cells immobilized in (hydro-)gels as monoculture (one cell type) or coculture
(at least two cell types);
2. Complexity level 2: multicellular aggregates consisting of one cell type in 3D scaffolds or in
scaffold-free cultures;
3. Complexity level 3: multicellular aggregates consisting of at least two cell types in 3D scaffold-











Figure 2. (A) Complexity levels defined by means of the applied 3D cell culture technique and with
respect to the existing 3D microenvironment. (B) Differentiation between superfusion and perfusion of
different 3D cell cultures. (C) Frequently used micro-bioreactor (MBR) types: 1. based on spinner flasks
or stirred tank systems, 2. rotating wall vessels (RWVs), 3. fluidic MBR, 4. hollow fiber bioreactors,
and 5. MBR for mechanical stimulation. The sketches show examples of the structure of the respective
MBRs. Details are discussed in review part II.
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With respect to the fluid flow mode in the context of microfluidic bioreactors, the term perfusion is
now used almost inflationary for all fluidic models. In the medical context, perfusion is defined as the
flushing of a blood vessel or the lymphatic system with a liquid. In a broader meaning, perfusion also
refers to the fluid flow through three-dimensional cell constructs or scaffolds. Systems in which only
cell layers are flushed, or tissues or scaffolds are flushed around them, do not fulfil these definitions.
This is generally called superfusion or perifusion [1]. The perfusion of tissues/scaffolds can be clearly
differentiated from superfusion. However, the distinction between superfusion and perfusion of
(blood) vessels is difficult to determine in the current in vitro models. Therefore, in the context of this
review, systems in which the medium flows through a channel surrounded by cells are considered to
be part of a perfusion system (Figure 2B).
In order to realize a medium flow around or through the 3D cell-constructs/scaffolds or tissues in
the MBRs, several bioreactor types have been established in the last years including (1) stirred systems
or spinner flasks, (2) rotating wall vessels (RWVs), (3) microfluidic MBRs, and (4) hollow fiber
bioreactors. Especially in the case of microfluidic MBR there are various designs enabling perfusion
of the cell-based constructs/scaffolds in addition to superfusion (Figure 2C). Furthermore, in MBRs
designed for mechanical stimulation ((5) in Figure 2C) the medium flow or mass transport through
the 3D cell culture emerges by stretching or compressing the cell-based construct/scaffold or tissue.
These are mostly in-house developments of the labs and details are presented in the second part of
this review.
3. Results
In order to give the reader an overview of the MBR configurations, the materials used for
fabrication, and 3D cell culture techniques employed in the available literature, we analyzed the
following parameters in 5-year periods: (i) the complexity level of the underlying 3D cell culture
technique (Figure 3), (ii) the frequencies of the MBR types (Figure 4), (iii) the materials used for MBR
fabrication (Figure 5), (iv) the complexity level for scaffold-based and scaffold-free applications in
relation to the MBR type (Figure 6), (v) the application field of the MBR types (Figure 7), and (vi) the
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Figure 3. Distribution of studies in the period from 2000 to 2020 with regard to complexity level
(for definitions, see “Section 2”). The number of the respective publications is shown in brackets.
* status as per 9 July 2020.
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Regarding the distribution of the studies over time with regard to publication date and complexity
level, it can be seen from Figure 3 that applications of complexity level 2 contribute a considerable
portion to the total number of publications (123 out of 192). Complexity levels 1 and 3 are less
represented in this area and share a similar proportion with 29 and 40 publications, respectively.
This distribution reflects the notion that 3D aggregates of the same cell type are the most popular
model systems in the field of MBR culture.
Of the 192 publications falling in the time frame between 2000 and 2020 (9 July 2020), an increase
in the publication number from 25 in the 5-year period of 2000–2004 to 43 in the period of 2005–2009,
to 66 in the period of 2010–2014 can be observed. In the period of 2015–2019 a slight decrease to
57 publications in total can be detected. With respect to the temporal distribution of the study numbers
within the complexity level groups, our analysis further demonstrates that the number of studies
using cell culture configurations with complexity levels 1 and 2 in MBRs peaked from 2005 to 2014
and from 2010 to 2014, respectively. In contrast, the number of published studies on complexity level
3 approaches in MBRs increased continuously during the evaluation period. This trend indicates that
cell culture models made of different cell types gain in importance within the area of 3D cell culture
in MBRs.   
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Figure 4. Distribution of micro-bioreactor types from 2000 to 2020 in the literature under study.
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If the analysis is done with regard to the used bioreactor type in the same 5-year periods, it is
clearly demonstrated that MBR systems with integrated microfluidics are the most prominent ones,
followed by RWV type bioreactors (Figure 4). The use of MBRs for mechanical stimulation and hollow
fiber MBRs take an intermediate position and vary between the specified periods. Furthermore, it is
interesting to note that MBR types, developed at a very early stage of 3D-bioreactor culture, such as











and spinner  flasks, MBR  for mechanical stimulation and hollow  fiber MBR. Abbreviations: PDMS 
(polydimethylsiloxane), PC  (polycarbonate), PMMA  (Poly(methylmethacrylate)), PS  (Polystyrene), 
PU  (polyurethane),  PES  (polyethersulfone),  PVDF  (polyvinylidene  fluoride);  “other  polymers” 
include  the  publications  with  the  less  frequently  applied  materials  stereolithography  resin, 
polyethylene terephthalate, polylactic acid, polytetrafluoroethylene, PU (individually), polyethylene, 
polyoxymethylene,  polypropylene,  polyether  ether  ketone;  the  category  “unknown  materials” 
includes publications in which the applied MBR materials were not further specified. 
As described earlier, parameters of  the 3D microenvironment, such as gradients of signaling 
molecules, cell/cell‐ and cell/ECM‐interactions, determine  the cellular behavior  in vitro. Hence,  in 
order  to  induce or maintain  tissue  specific  cell differentiation  and  functions, various  cell  culture 
Figure 5. Distribution of studies i t e period from 2000 to 2020 with regard to the materials used
for MBR fabrication. The materials used for the most common types of MBR, namely fluidic MBR,
RWVs and spinner flasks, MBR for mechanical stimulation and hollow fiber MBR. Abbreviations:
PDMS (polydimethylsiloxane), PC (polycarbonate), PMMA (Poly(methylmethacrylate)), PS (Polystyrene),
PU (polyurethane), PES (polyethersulfone), PVDF (polyvinylidene fluoride); “other polymers” include
the publications with the less frequently applied materials stereolithography resin, polyethylene
terephthalate, polylactic acid, polytetrafluoroethylene, PU (individually), polyethylene, polyoxymethylene,
polypropylene, polyether ether ketone; the category “unkno n materials” includes publications in which
the applied MBR materials were not further specified.
Wh n ooking c oser to the materials used for bioreactor manufacturing, it can be see that
polymer-based materials represent the major part. Polydimethylsiloxane (PDMS), individ ally or in
combination with other polymers or glass, is thereby the most commonly used material and mainly
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applied when microfluidics is asked to be incorporated (Figure 5). This may be due to numerous
in-house developments and optimizations in the field of fluidic MBR as PDMS is comparatively
easy to process and to shape. Occasionally, 3D printed systems are also used [2,3]. Another large
group of widely used MBRs, the RWV bioreactor type, is usually based on commercially available
systems, e.g., from Synthecon. These are available as plastic or glass versions. However, the RWV
version used in the corresponding publications were not always specified and therefore summarized
under unknown materials in Figure 5. In addition to the polymer-based materials, stainless steel,
besides glass, is often used in microfluidic systems and MBRs for mechanical stimulation. As the
latter MBR type is primarily used in bone or cartilage tissue reconstruction to simulate the in vivo
situation by applying mechanical forces, tougher materials like stainless steel are used for construction
to meet the biomechanical requirements. In the group of hollow fiber MBRs, polyethersulfone (PU) and
polyvinylidenedifluoride (PVDF) predominate as these materials are mainly used for the capillaries or










“tissue  engineering”,  and  “high‐throughput‐screening  (HTS)”,  split  them  according  to  the 
complexity level in subgroups and examined the MBR distribution within the respective subgroups. 
For this, we deduced the main application area indicated in the papers or categorized them by the 
soundness  and  impact of  the  results when no main  application was  specified, or more  than one 
application possibility was given. The presented results may therefore not be considered as strictly 
Figure 6. 3D cell culture techniques and their application described in the literature under study.
The techniques were organized with regard to their complexity level, the use and nature of the scaffolds
and their applicatio in the various MBR types. The numbers in parentheses refer to the number of
corresponding publications.














publications using  complexity  level  2  cell  cultures predominate  and  the number of  studies with 
complexity level 3 was lowest. The same trend holds true for the HTS group. The pie charts further 




of  uniform  and  complex  cell  aggregates which  are  often  used  for  in  vitro models.  Table  1  lists 
publications that are included in our analysis. 
Figure 7. Application fields of the MBRs described in the analyzed literature with respect to the
complexity levels. The dimensions of the pie charts reflect the number of publications in the respective
application group and complexity level subgroup. Number of publications: 192.
As described earlier, parameters of the 3D microenvironment, such as gradients of signaling
molecules, cell/cell- and cell/ECM-interactions, determine the cellular behavior in vitro. Hence, in order
to induce or maintain tissue specific cell differentiation and functions, various cell culture techniques
have been established which were classified in three complexity levels in the present review as described
in Section 2 (Figure 2A). The techniques can further be divided in two groups, namely techniques
using scaffolds for the immobilization and organization of the cells and scaffold-free techniques
(Figure 6). Both techniques utilize the self-organizing, polarizing, and adhesion capabilities of the
cells to form multicellular aggregates within scaffolds or without supporting structures. To give an
overview of the distribution of the different techniques in the literature under study, we analyzed
the described cell culture techniques with regard to complexity level, the use and nature of the
scaffolds and their application in the various MBR types (Figure 6). The results from our literature
analysis reveal that in the scaffold-based group the majority of studies used cell culture approaches
with a complexity level of 2, i.e., multicellular aggregates of one single cell type (Figure 6). In the
scaffold-free group, cell aggregates with one cell type (complexity level 2) also comprise a greater
proportion when compared to complexity level 3 but is less strongly represented than compared to the
scaffold-based group. If we take a look at the application of the specific cell culture techniques in the
different MBR systems, our analysis demonstrates that gel-based scaffolds, composed, amongst others,
of collagen, hyaluronan, polyethylene glycol, or Matrigel®, are most frequently used for 3D culture
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in microfluidic MBR systems, followed by sponge-like and fibrous scaffolds, and microstructured
substrates. Microbead-based scaffolds were exclusively described in studies using RWVs and thus
could only be assigned to this type of MBR, whereas spheroids are commonly applied in RWVs
and spinner flask/stirred tank systems. This distribution can be explained by the immobilizing and
structuring function of the scaffolds and hollow fibers, which is a prerequisite for proper perfusion
or superfusion in microfluidic and hollow fiber MBRs. In contrast, the concept of RWV systems is
to provide the nutrient and gas supply of the cells by stirring or rotating movement of the 3D-cell
constructs such as microbeads and spheroids. Regarding the techniques used frequently in MBRs for
mechanical stimulation, gel-based, fibrous, and sponge-like scaffolds, as well as decellularized tissues




















Figure 8. Distribution of the c lls used in the publicati der study with respect to the origin of
the cells (A), the target tissue /organs (B), and the type lls (C). Others: bladder, placenta, muscle,
endometrium, skin, vaginal epithelium, retina, kidne , r as, nerves, connective tissue, and brain.
Number of publications: 192.
Since 3D culture techniques have proven useful in many applications we grouped the papers
into the three most common fields of application that could be extracted, namely “in vitro models”,
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“tissue engineering”, and “high-throughput-screening (HTS)”, split them according to the complexity
level in subgroups and examined the MBR distribution within the respective subgroups. For this,
we deduced the main application area indicated in the papers or categorized them by the soundness
and impact of the results when no main application was specified, or more than one application
possibility was given. The presented results may therefore not be considered as strictly as Figure 7
proposes since there are smooth transitions possible, especially between the groups “in vitro models”
and “tissue engineering”.
As presented in Figure 7, most of the analyzed studies could be assigned to the “in vitro models”
group and were mainly done with cell cultures of complexity level 2, i.e., cell aggregates of one
cell type. In this group, approaches that used two or more cell types for the in vitro model, i.e.,
complexity level 3, represented the second largest proportion or subgroup which was followed by
complexity level 1 techniques using immobilized cells in (hydro-) gels. In the “tissue engineering”
group again publications using complexity level 2 cell cultures predominate and the number of studies
with complexity level 3 was lowest. The same trend holds true for the HTS group. The pie charts
further reveal that microfluidic MBRs are most strongly represented throughout all groups, and prevail
particularly in the HTS group. The latter might be due to the possibility to integrate analysis features
into microfluidic MBRs which support data evaluation in HTS systems. The second largest share
among the MBR systems are represented by RWVs and spinner flasks as they support the generation of
uniform and complex cell aggregates which are often used for in vitro models. Table 1 lists publications
that are included in our analysis.

















1 [4,5] [6–24] [25–32]
2 [33–35] [36–71] [3,24,72–132] [133–144] [145–153]
3 [154–156] [157–165] [2,166–190] [191] [192]
Since our literature analysis revealed that most publications under study involve “in vitro models”
we were next interested in the distribution of the applied cell types and target tissues/organs in the
MBR field (Figure 8). With respect to the origin of the cells, the examination of the published literature
between 2000 and 2019 revealed that at the beginning of the 2000s, human and rodent cells were
the most common models, applied in 41% (human cells and combinations) and 45% of the studies,
respectively (Figure 8A). By comparison, the share of publications using cells from other mammals,
mainly bovine for bone and cartilage models, was at 14% and thus relatively low. During the period
under review, the usage of human cells individually or in combination with cells of other origin
increased to about 80% by 2019, whereas publications using rodent and other mammalian models
declined to 13% and 4%, and thus play a minor role in this research field by now. The reason for this
trend becomes apparent when the distribution of the target tissues/organs is analyzed (Figure 8B).
From this follows that most published studies address the liver, with the primary objective to establish
liver models for metabolism and toxicity testing (data not shown). Since meanwhile it is commonly
agreed upon that rodent hepatocytes do not adequately reflect human hepatocyte functions with
respect to the panel of detoxification enzymes and proteins, in vitro models based on rodent primary
cells lost most of their importance. A similar situation may prevail for other tissues displayed in
Figure 8B. Regarding the type of cells cultured in the MBR systems, our literature research demonstrates
that in the early 2000s a higher number of studies used primary cells, i.e., differentiated and/or mature
cells, followed by stem and progenitor cells, and to a lesser extent cell lines (Figure 8C). Interestingly,
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the application of primary cells considerably increased until 2014 and sharply decreased from 2015
to 2019 to the same level as cell lines which also increased to a lesser extent in the same period.
The progress in the field of stem cell research however may lead to a moderate but constant increase of
the publications using stem and progenitor cells, and thereby is gradually replacing primary cells and
cell lines.
As mentioned at the beginning, it is not always easy to distinguish MBR approaches and
organ-on-a-chip (OoC) systems, as definitions are not consistent and transitions are fluid. OoCs are
defined as microengineered devices with microfluidic channels with at least one cell culture
compartment in which functional units of organs are modeled [193–195]. Organ-on-a-chip systems do
not only mimic human organs’ in vivo physiology, for instance by providing an active flow, they also
integrate actuators or sensors for further analysis.
To give the reader an idea of the number of published studies using OoC in comparison to MBR
systems we conducted a second literature research with the term [(“organ on chip” OR “organ-on-chip”
OR “organ on a chip” OR “organ-on-a-chip”) AND (“tissue engineering” OR “three dimensional
cell culture” OR “3d cell culture” OR “3-d cell culture”)]. As depicted in Figure 9 the number
of recently published studies using 3D cell cultures in MBR has been almost constant in the last
years, whereas the number of OoC-related publications has increased dramatically in the last 5 years.
At second glance, however, the published systems do not always reach the complexity defined for
OoCs, such as integrated sensors, respectively, actors or modular combination of different organ
models. Although MBRs are often referred to as organ-on-chip systems [81], a distinction was made
between OoCs and MBRs as described above. Since OoC systems are repeatedly considered to be
among the top emerging technologies [196], it could be speculated that the use of this keyword is to
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models, and  in  cell  function analysis of  low  cell numbers or  even on a  single‐cell  level will also 
advance in the next years. With respect to the bioreactor systems, this trend manifests by a decrease 
in the number of MBR publications which is accompanied by a pronounced increase in the organ‐on‐
Figure 9. Search results in the database PubMed between 2000 and 2020 with the search terms 1–3 used in
this review for micro-bioreactors (Term 1: 3D cell culture” AND “microbioreactor; Term 2: (bioreactor OR
microbioreactor OR micro-bioreactor) AND (“three-dimensional cell culture” OR “3D cell culture” OR
“3-D cell culture”); Term 3: (microbioreactor OR micro-bioreactor) AND “tissue engineering” compared
to organs-on-a-chip (search term: (“organ on chip” OR “organ-on-chip” OR “organ on a chip” OR
“organ-on-a-chip”) AND (“tissue engineering” OR “three dimensional cell culture” OR “3d cell culture”
OR “3-d cell culture”), status as per 27 October 2020).
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4. Conclusions
The results of our systematic review revealed that MBRs became very popular between 2000 and
2014, with microfluidic MBRs being most strongly represented in the fields of fundamental research
with in vitro models, tissue engineering, and HTS. With respect to the cell culture configuration used in
the MBR systems during this period, 3D aggregates of the same cell type, consisting mainly of human
primary cells or cell lines are the most frequently used technique in this period, irrespective of whether
scaffold-based techniques are applied or scaffold-free ones. Our analysis further demonstrates that
MBR systems established very early in bioreactor-based 3D culture and tissue engineering are still
used until today, possibly due to the commercialization of the systems. In the last 5 years, however,
a new trend can be observed towards more complex 3D culture systems with an increasing number of
publications using 3D coculture models, i.e., cell cultures consisting of at least two cell types, and human
cells. Within the group of human cells, stem and progenitor cells have become very popular. This trend
towards more complex human stem/progenitor cell-based in vitro models requires however further
miniaturization of the systems as cell/tissue sources, especially with respect to personalized medicine,
are often limited or yield low cell amounts. Consequently, further developments in 3D cell culture
techniques, such as unique media formulations for coculture models, and in cell function analysis of
low cell numbers or even on a single-cell level will also advance in the next years. With respect to the
bioreactor systems, this trend manifests by a decrease in the number of MBR publications which is
accompanied by a pronounced increase in the organ-on-a-chip literature. This most likely reflects the
progress made in manufacturing and/or cell culturing techniques as well as the increase in experience
made by using MBRs.
In part II of the review (Systems and Applications) we will have a closer look at the micro-bioreactors
and the specific applications that they have been used for.
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